Cost-Effectiveness Analysis of Caspofungin Compared to Conventional Amphotericin B (C-AMB) for Empirical Antifungal Therapy in Febrile Neutropenic Patients in Thailand
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.042
https://www.valueinhealthjournal.com/article/S1098-3015(14)01972-X/fulltext
Section Title :
Infectious Disease Outcomes Research Studies
Section Order :
2048
First Page :
A724
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01972-X&doi=10.1016/j.jval.2014.08.042